CORLUXIN, created in 2011 (United States), from 2 sister brands and 2214 competing brands. The CORLUXIN brand is owned by Corcept Therapeutics, a company listed in New York. CORLUXIN belongs to the Biotechnology business sector.

CORLUXIN is a brand of Corcept Therapeutics (CORT) Share price

Share price and profitability of the share Corcept Therapeutics (CORLUXIN)

Buy Corcept Therapeutics share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 25.32

Portfolio valuation
Corcept Therapeutics (CORLUXIN) over 5 years* USD 55.78

Stock market history Corcept Therapeutics (CORLUXIN)

Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more